Who Owns IRulya Therapeutics Stock?
NASDAQ: IRLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 12.11%
- Held by insiders
- 1.01%
- Institutional holders
- 37
- Institutions 12.1%
- Insiders 1.0%
- Public and other 86.9%
Who owns IRulya Therapeutics stock?
Institutional investors own about 12.1% of IRulya Therapeutics's shares, spread across 37 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.01% of IRLA.
The largest institutional holders are Janus Henderson Group Ltd. (15.82%), Ikarian Capital, LLC (0.88%) and Squadron Capital Management LLC (0.83%). Together, the top 10 institutions control 20.2% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their IRLA positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IRLA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Janus Henderson Group Ltd. | 1.71M | 15.82% | +100.0% |
| Ikarian Capital, LLC | 95.65K | 0.88% | +32.4% |
| Squadron Capital Management LLC | 90.00K | 0.83% | +122.9% |
| Millennium Management Llc | 72.25K | 0.67% | +2.1% |
| Balyasny Asset Management LP | 69.97K | 0.65% | 0.0% |
| Acuta Capital Partners LLC | 52.92K | 0.49% | +100.0% |
| Birchview Capital, LP | 40.60K | 0.37% | +100.0% |
| Boothbay Fund Management, LLC | 21.29K | 0.20% | +53.0% |
| Jane Street Group, LLC | 20.16K | 0.19% | +59.4% |
| Seven Fleet Capital Management LP | 11.99K | 0.11% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IRLA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 12.04K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 5.34K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.25K | 0.01% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 1.15K | 0.01% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 580 | 0.01% |
| Guggenheim Active Allocation Fund | 1 | 0.00% |
Frequently asked questions
Who is the largest shareholder of IRulya Therapeutics?
Janus Henderson Group Ltd. is the largest institutional shareholder of IRLA, owning 15.82% of shares outstanding (1.71M shares) as of its latest 13F filing.
What percentage of IRulya Therapeutics is owned by institutions?
Institutions own about 12.1% of IRLA shares and 12.2% of the public float.
How much of IRulya Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.01% of IRLA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.